t(1;22)(p13;q13) RBM15/MKL1
2001-06-01 Jean-Loup Huret   Affiliation1.Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers France
Clinics and Pathology
Disease
Phenotype stem cell origin
Etiology
Epidemiology
Clinics
Cytology
Treatment
Prognosis
Cytogenetics
Additional anomalies
Variants
Genes Involved and Proteins
Result of the Chromosomal Anomaly
Description
Oncogenesis
Highly cited references
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 32408494 | 2020 | RNA-Binding Proteins in Acute Leukemias. | 255 |
| 42680676 | 2026 | RBM15 in leukemogenesis: an emerging regulator at the interface of RNA biology and hematopoiesis. | 102 |
| 12944485 | 2003 | Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes. | 68 |
| 40801789 | 2025 | PRMT1-mediated metabolic reprogramming promotes leukemogenesis. | 62 |
| 40435410 | 2025 | RBM15-MKL1 fusion protein promotes leukemia via m6A methylation and Wnt pathway activation. | 54 |
| 17283045 | 2007 | Rbm15 modulates Notch-induced transcriptional activation and affects myeloid differentiation. | 51 |
| 22927943 | 2012 | Rbm15-Mkl1 interacts with the Setd1b histone H3-Lys4 methyltransferase via a SPOC domain that is required for cytokine-independent proliferation. | 42 |
| 28112737 | 2017 | Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes. | 41 |
| 27114462 | 2016 | Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study. | 39 |
| 26215111 | 2015 | Heterogeneous cytogenetic subgroups and outcomes in childhood acute megakaryoblastic leukemia: a retrospective international study. | 38 |
| 18710951 | 2008 | OTT-MAL is a deregulated activator of serum response factor-dependent gene expression. | 32 |
| 36003795 | 2022 | Revealing the intratumoral heterogeneity of non-DS acute megakaryoblastic leukemia in single-cell resolution. | 22 |
| 36798463 | 2023 | t(1;7;22)(p13;q21;q13) is a novel 3-way variant of t(1;22)(p13;q13) neonatal acute megakaryoblastic leukemia: A case report. | 18 |
| 25838902 | 2015 | Neonatal acute megakaryoblastic leukemia mimicking congenital neuroblastoma. | 15 |
| 28239626 | 2017 | Acute Myeloid Leukemia With RBM15-MKL1 Presenting as Severe Hepatic Failure. | 14 |
| 35844738 | 2022 | Case Report: The Value of Genomic Analysis in a Case of Megakaryoblastic Leukemia With Atypical Initial Manifestation. | 12 |
| 29806701 | 2018 | Neonatal leukaemia. | 0 |
| 34497221 | 2021 | [Acute leukemia of infants and neonates]. | 0 |
| 40060447 | 2025 | RBM15-MKL1 fusion protein promotes leukemia via m6A methylation and WNT pathway activation. | 0 |
| 19860179 | 2009 | [Classification of myeloid leukemias]. | 0 |
| 28063190 | 2017 | Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndrome. | 0 |
| 30842387 | 2019 | [Prognostic significance of chimeric fusion gene analysis in pediatric acute megakaryoblastic leukemia]. | 0 |
| 29427526 | 2018 | NUP98-BPTF gene fusion identified in primary refractory acute megakaryoblastic leukemia of infancy. | 0 |
| 15849773 | 2005 | RBM15-MKL1 (OTT-MAL) fusion transcript in an adult acute myeloid leukemia patient. | 0 |
| 41173236 | 2026 | Lineage switch from B-ALL to AML via an intervening MDS/MPN phase with acquisition of RBM15::MKL1 and RAD21 mutation. | 0 |
| 28412998 | 2017 | New hPSC-based human models to study pediatric Acute Megakaryoblastic Leukemia harboring the fusion oncogene RBM15-MKL1. | 0 |
| 23531517 | 2013 | NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern. | 0 |
| 41874820 | 2026 | Acute megakaryoblastic leukemia with RBM15::MKL1 fusion presenting as neonatal acute liver failure: rescued by living-donor liver transplantation. | 0 |
| 42934831 | 2026 | Immunophenotypic and genetic features of pediatric non-DS AMKL versus non-AMKL AML: A single-center study in China. | 0 |
| 32572949 | 2020 | Acute megakaryoblastic leukaemia with t(1;22)(p13·3;q13·1)/RBM15-MKL1 in an adult patient following a non-mediastinal germ cell tumour. | 0 |
| 24743787 | 2014 | Detection of RBM15-MKL1 fusion was useful for diagnosis and monitoring of minimal residual disease in infant acute megakaryoblastic leukemia. | 0 |
| 22469944 | 2012 | Hemophagocytosis by leukemic megakaryoblasts in acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13);RBM15-MKL1. | 0 |
| 32743872 | 2021 | TERT promotor variant associated with poor clinical outcome in a patient with novel RBM15-MKL1 fusion-positive pediatric acute megakaryoblastic leukemia. | 0 |
| 31802626 | 2020 | Acute megakaryoblastic leukemia with t(1;22)(p13.3;q13.1); RBM15-MKL1 mimicking hepatoblastoma in an infant: The role of karyotype in differential diagnosis. | 0 |
| 21370421 | 2011 | Acute megakaryoblastic leukemia with a four-way variant translocation originating the RBM15-MKL1 fusion gene. | 0 |
Bibliography
No bibliography items were found for this article.
Summary
Fusion gene

Citation
Jean-Loup Huret
t(1;22)(p13;q13) RBM15/MKL1
Atlas Genet Cytogenet Oncol Haematol. 2001-06-01
Online version: http://atlasgeneticsoncology.org/haematological/1005/t(1
Historical Card
1999-11-01 t(1;22)(p13;q13) RBM15/MKL1 by Jean-Loup Huret  Affiliation
1998-01-01 t(1;22)(p13;q13) RBM15/MKL1 by Jean-Loup Huret  Affiliation
1997-08-01 t(1;22)(p13;q13) RBM15/MKL1 by Jean-Loup Huret,Jean-Loup Huret  Affiliation
